6505--COLESTIPOL HCL 1GM TAB 120CT and DESONIDE 0. 05% CREAM, TOP - 762 TUCSON - AP0181 and AP0182

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is soliciting quotes for two pharmaceutical line items: Colestipol HCL 1GM Tablets (120 count bottles) and Desonide 0.05% Cream. Vendors must submit signed SF 1449 forms, completed pricing schedules, valid state wholesale distributor licenses, and Buy American Act certificates by January 30, 2026, at 3:00 PM Central Time to Jennifer.Coleman4@va.gov. Key requirements include compliance with Drug Supply Chain Security Act provisions, GS1-128 or HIBCC-compliant bar coding at the unit-of-use package level, and expiration dates no less than 12 months from delivery. The solicitation incorporates standard FAR clauses for commercial products, including inspection and acceptance rights, patent indemnity, and termination provisions. Offerors are limited to one quote per vendor, and vendors may propose alternate National Drug Codes with adjusted quantities if noted in vendor comments.

This is an unrestricted acquisition with a small business set-aside designation, and no incumbent contractor or estimated award value is specified in the solicitation documents. The procurement requires delivery of 1,704 units of Colestipol HCL and 5,904 units of Desonide 0.05% Cream to the Tucson Consolidated Mail Outpatient Pharmacy at 3675 E. Britannia Drive, Tucson, Arizona 85706 on an FOB Destination basis. Delivery must occur within 10 days after receipt of order, with invoices paid upon final acceptance and submitted electronically in accordance with VAAR Clause 852.232-72. The solicitation was posted on January 23, 2026, with the offer due date of January 30, 2026, providing vendors a seven-day response window. No specific evaluation criteria beyond compliance with technical and commercial requirements are detailed in the available documentation.